Our hypothesis is that the decreased MMP-9 levels found in our DVT patients, more expressive in patients with severe PTS, may contribute to a poor vascular repair process, and consequently to the clinical manifestations of PTS. The gene discussed is MMP9; the disease is deep vein thrombosis.